Nebulizer Market By Type (Jet Nebulizer, Mesh Nebulizer, and Ultrasonic Nebulizer), By Portability (Portable Nebulizer and Tabletop Nebulizer), By Applications, By End-User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Report Overview

The Nebulizer Market size is expected to be worth around USD 2.1 billion by 2032 from USD 1.2 billion in 2022, growing at a CAGR of 6.1% during the forecast period from 2023 to 2032

Nebulizers are devices used to treat respiratory diseases in patients by administering the medication directly into the lungs. They are usually made up of a motor, cup, and tubing, mouthpiece. Using oxygen, ultrasonic power for breaking up the liquid drug into aerosols, and compressed air turn the liquid medicine into a fine mist.

Nebulizers are usually prescribed to individuals who cannot breathe deeply by using an inhaler. The significant growth is attributed to the increasing demand for home Medical devices, the rising incidence of chronic respiratory diseases, and the rising geriatric population.

Key Takeaways

• Market Growth: The nebulizer market is to grow at a CAGR of 6.1% from 2023 to 2032, reaching USD 2.1 billion by 2032.
• Type Dominance: Jet nebulizers hold a 61% market share, favored for efficient drug delivery.
• Portability Preference: Table-top nebulizers lead to higher adoption compared to portable ones.
• COPD Prevalence: The COPD segment dominates due to rising prevalence and advanced technology.
• End-user Landscape: Hospitals & clinics had the largest market share in 2022.
• Market Drivers: Factors include sedentary lifestyles, pollution, and the aging population.
• Market Restraints: Challenges include alternative treatments and disease transmission concerns.
• Innovation Opportunities: Growing demand for vibrating mesh nebulizers and home healthcare devices.
• North America dominated the market in 2022, with a 40% revenue share.
• Asia Pacific is the fastest-growing market, with a high geriatric population and government initiatives promoting technological innovations.

Type Analysis

The jet nebulizer segment dominated the global market with a revenue share of 61%

Based on type, the global nebulizer market is segmented into jet, mesh, and ultrasonic types. Among these types, the jet nebulizer accounted for the largest market share in the market for nebulizers in 2022 and is expected to grow more during the forecast period. The low device cost, efficient design for drug delivery, and ease of handling nebulizers have increased demand for jet nebulizers over the years.

They effectively deliver formulations that cannot be delivered by pressurized metered-dose and dry powder inhalers. Additionally, the nebulizer is available in different designs, including jet nebulizers, collection bags, corrugated tubes, breath-enhanced jet nebulizers, breath-actuated jet nebulizers, and others.

The mesh nebulizer segment is anticipated to witness significant market growth during the forecast period owing to the minimized drug loss and compact-size devices that are technologically advanced. In addition, the growth of mesh nebulizers is likely to be accelerated due to significant factors such as increased patient acceptance, portability, quick treatment, and convenience. Furthermore, further growth is achieved due to the increasing adoption of mesh nebulizers due to accurate drug delivery to lower residual volumes and lungs.

Portability Analysis

The table-top segment accounted to hold the largest market share

By portability, the market is further divided into portable nebulizers and tabletop nebulizers. The table-top segment is estimated to register the largest market share during the forecast period. The significant factors contributing to this largest share include the increase in the use of tabletop nebulizers owing to the availability of reimbursement policies in well-developed markets and the operational benefits offered by these devices.

The portable nebulizer segment witnessed steady growth over the forecast period.The rising adoption and several players developing portable devices are expected to surge the growth of this segment over the forecast period.

Applications Analysis

The COPD segment was accounted as the dominant segment in 2022

Based on applications, the global market for nebulizers is bifurcated into COPD, asthma, cystic fibrosis, and other applications. COPD (chronic obstructive pulmonary disease) is anticipated to account for the largest revenue share in the global market for nebulizers during the forecast period due to the rising prevalence of COPD. The recent advancements in technology have made nebulizers more patient-friendly and portable.

In addition, the various medication types are also primarily available in the nebulized formulations, including long-acting muscarinic receptor antagonists, long-acting beta2-agonists (LABAs), steroids, antibiotics, and mucolytics. All these features allowed individuals with COPD to use the nebulizers outside the acute settings like hospitals or clinics, boosting the segment growth. Furthermore, the companies’ research & development activities in rapidly advancing technologies are further expected to propel the segment growth.

The Asthma segment is anticipated to witness significant market expansion during the forecast period. Asthma is described as a non-communicable disease affecting adults and children and is a most common chronic disorder. Asthma has become the most prevalent respiratory condition globally due to the increasing pollution in most regions.

End-user Analysis

In 2022, the hospitals & clinics held the largest market share

Based on end-user, the global nebulizer market is classified into hospitals & clinics, home healthcare, emergency centers, and other end-users. Among these, the hospitals accounted for the highest market revenue share in 2022. Due to the larger patient pool and favorable reimbursement policies, hospitals are an active part of the healthcare industry and a profitable revenue source for the entire industry. Hence, multiple companies invest continuous efforts in revenue and marketing strategies to endorse their services/products among the hospitals.

Home healthcare devices are continuously gaining popularity, increasing market share in recent years. Technological advancements and product miniaturization are increasing the adoption of home healthcare devices. Moreover, the rising aged population, growing need to curb healthcare expenditure, and high incidence of target diseases are predicted further stimulate the market growth. Patients are increasingly shifting towards home healthcare because it is a cost effective alternative compared to hospital stays. In addition, factors such as technological innovations, easy availability of compact nebulizers, and ideal for home use are subjected to further growth of this segment.

Key Market Segments

Based on Type

• Jet Nebulizer
• Mesh Nebulizer
• Ultrasonic Nebulizer

Based on Portability

• Portable Nebulizer
• Tabletop Nebulizer

Based on Applications

• COPD
• Asthma
• Cystic Fibrosis
• Other Applications

Based on End-User

• Hospitals & Clinics
• Home Healthcare
• Emergency Centers
• Other End-Users

Drivers

Rising incidence of respiratory disorders to surge the market growth

Busy schedules and a lack of physical activities due to sedentary lifestyles have led to the growing prevalence of obesity worldwide. Also, the high consumption of alcohol and tobacco is considerably leading to the increase in chronic respiratory disorders, which in turn is increasing nebulizer sales.

Apart from this, rising pollution levels due to the expansion of industries and the growing adoption of private vehicles is other major factor contributing to the global nebulizer demand. In emerging economies, the prevalence is increasing more rapidly, resulting in many patients suffering from respiratory disorders. Therefore, these regions’ government promotes early diagnosis and treatment, thereby increasing patients undergoing the treatment and the demand for the product.

Rising geriatric population

The growing number of aged individuals has led to a rise in the usage of home healthcare devices, positively driving the market’s growth. In addition, many organizations are taking initiatives toward spreading awareness about the available options for treating respiratory disorders.

Restraints

Availability of alternative treatment options and risk of disease transmission to restrict the market growth

Certain concerns are raised regarding the safety of respiratory devices for the transmission of infection. The key factor, such as the risk of transferring the infection from the tubing of nebulizers to the patient’s lungs or the infection transmission from the unsterile chambers of the devices, are likely to limit the recommendations given by the physicians for the usage of these devices. Hence, due to these factors over the past years, some centers have shifted from using a nebulizer to (pMDI) metered dose inhalers with valved holding chambers.

Metered dose inhalers are typically small, easy to carry, portable, and offer numerous operational and clinical benefits in asthma treatment. However, the increasing availability of alternative options and the cost of treatment are also hindering the segment’s growth. Therefore, the further demand for nebulizers is expected to face tough competition with increasing acceptance of alternative devices to treat respiratory diseases in individuals.

The increasing preference for inhalers from healthcare providers, including metered-dose inhalers for the treatment of asthma, the operational and clinical benefits of metered-dose inhalers for treating asthma, as well as the lower cost of these devices has led to a preferential shift of individuals from the nebulization devices to inhalers. Moreover, the limited reimbursement policies in emerging countries and the high costs of mesh nebulizers are expected to restrict market growth over the forecast period.

Opportunities

Increasing innovation by key players is resulting in a preferential shift towards vibrating mesh nebulizers

Rising innovations by key players with the development of technologically advanced devices, dispensing medication at a constant particle size, and making the whole administration experience easy have increased the utilization of vibrating mesh nebulizers. Therefore, this device’s comfortable and easy use is expected to contribute to the growing adoption of these systems.

Such device innovations are anticipated to increase the demand for portable devices. Moreover, an increase in collaborations among the key players to extend their market reach and the increasing awareness among healthcare providers about innovative products are likely to boost market growth.

Trends

Rising demand for home healthcare devices

The rising healthcare services costs and long hospital stays have led to a frequency shift of patient treatment towards home healthcare settings. In addition, the expensive hospital stays to treat respiratory disorders such as (COPD)chronic obstructive pulmonary disease, asthma, and other respiratory disorders emphasize the patients take treatment at home healthcare setting. Owing to this factor, there is an increase in the adoption of home healthcare devices. This growing demand for inhaled drug delivery devices and the promotion of these products for home use by several healthcare organizations are expected to propel the growth of the nebulizer market in the near future.

Regional Analysis

North America dominated the market for nebulizers in 2022

North America dominated the global market with 40% of the revenue share in 2022. Due to the increasing number of respiratory disorders and government efforts such as favorable reimbursement policies, a well-established healthcare infrastructure, and a rise in customer awareness are the major factors responsible for market expansion. In addition, introducing technologically advanced devices in this region is predicted to upsurge the market growth. Furthermore, the increasing aged population in the United States is resulting in a consistent growth of nebulizers in this region.

Asia Pacific is the fastest-growing market during the forecast period because of the high geriatric population, government initiatives promoting technological innovations, and increasing focus on preventive care. In addition, the increase in patient awareness and the rise in healthcare expenditure in this region have increased the demand for these devices. In addition, the favorable taxation policies and low-cost manufacturing sites in the region have attracted key players to this market. Moreover, increased medical tourism in Asia Pacific regions such as India, Malaysia, the Philippines, and Singapore has helped grow the regional market.

Key Regions

• North America
  • The US
  • Canada
  • Mexico
• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America
• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Players Analysis

The nebulizer market is growing due to key players continuously introducing technologically advanced mesh nebulizers, creating numerous opportunities for the companies. Most companies are using mesh nebulizers for drug development. For the differentiation of products, companies are involved in adopting growth strategies such as acquisitions, collaboration, partnerships, and new product development.

Listed below are some of the most prominent nebulizer industry players.

Market Key Players

• Agilent Technologies, Inc.
• GF Health Products, Inc.
• Vyaire Medical, Inc.
• Rossmax International Ltd.
• DeVilbiss Healthcare LLC
• Koninklijke Philips N.V.
• GE Healthcare Technologies Inc.
• OMRON Corporation
• Vectura Group Ltd
• Allied Healthcare Products, Inc.
• Aerogen
• PARI Respiratory Equipment, Inc.
• Other Key Players

Key Industry Developments

• In July 2024 Acquisition: Agilent Technologies acquired Sigsense Tech, a company specializing in equipment tracking and management. The acquisition took place in July 2024, although the acquisition amount was undisclosed. This move aligns with Agilent’s strategic expansion into technology solutions enhancing lab operations and efficiency.
• In May 2023: Philips signed a deal with the U.S. government to significantly increase its production of hospital ventilators, which are critical in respiratory care, including nebulizer functions. The agreement, valued at $647 million, involved the delivery of 43,000 ventilators throughout the year. This production ramp-up was facilitated under the Defense Production Act, highlighting Philips’ commitment to meet urgent healthcare needs during the COVID-19 pandemic​.
• In April 2024: GF Health Products, Inc. announced the acquisition of Transfer Master Products, Inc., a company known for its high-quality adjustable beds for home and healthcare settings. This acquisition will enhance Graham-Field’s capabilities in the rehabilitation and homecare markets by expanding its bed and sleep support system offerings. This move aligns with Graham-Field’s strategy to diversify its product portfolio and strengthen its position as a global provider of healthcare equipment.
• In April 2024: GE Healthcare completed the acquisition of MIM Software, significantly enhancing its capabilities in imaging analytics and digital workflow solutions. This acquisition is part of GE Healthcare’s precision care strategy aimed at improving hospital efficiency and clinician effectiveness through advanced digital solutions. The transaction, which was funded with cash on hand, reflects GE’s commitment to integrating comprehensive digital solutions across various care areas, including oncology, cardiology, and neurology.

Report Scope